Home / Brands / Glenmark Therapeutics

Glenmark Therapeutics Recalls

1 recall on record · July 26, 2023 to July 26, 2023 · Drugs

July 26, 2023DrugsFDA

Glenmark Therapeutics, Inc. recalls Famotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark Therapeutics Inc., USA, Mahwa

Hazard: Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.

Glenmark Therapeutics Recalls | RecallWatchUSA